Stem Holdings, Inc. (OTCPK: STMH)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Stem Holdings, Inc. (OTCPK: STMH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $67.00 and employs 75 people.
trading between 0.00 and 0.00.
Tweenvest scores Stem Holdings, Inc. across four factors: quality 23/100. Its strongest factor is quality.
STMH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $67.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -7.51
- Dividend yield
- —
- Beta (5Y)
- -21.08
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.67M
- Employees
- 75
- Next earnings
- —
About Stem Holdings, Inc.
Stem Holdings, Inc. operates as a fully integrated enterprise within the cannabis and technology sectors. Its core activities involve the cultivation, production, distribution, and sale of both cannabis and cannabis-derived products. The company manages a diverse brand portfolio, which includes TJ's Gardens, TravisxJames, and Yerba Buena for flower and extracts, as well as Cannavore for edible treats. For the broad consumer market, they offer Doseology, a CBD-focused brand. Additionally, their technological offerings comprise the e-commerce delivery platforms Budee and Ganjarunner. As of September 30, 2021, Stem Holdings possessed ownership interests in 29 state-issued cannabis licenses. Specifically, these included 9 cultivation permits, 3 processing permits, 2 wholesale distribution licenses, 3 hemp production licenses, 7 dispensary licenses, and 5 adult-use medical retail licenses. Established in 2016, the company's headquarters are located in Boca Raton, Florida.
- ISIN
- US85858U3059
- Founded
- 2016
- Listed since
- Jan 8, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.